Blog | BioInformant

Cord Blood Banking Industry – Key Benchmarks to Track & Why to Care

December 15, 2025 By Cade Hildreth, Founder & President 2 Comments

The “Global Cord Blood & Tissue Banking Industry Report – Market Size, Segmentation, and Forecasts” market report reveals key benchmarks to track and why you should care. Benchmarks are critical to assess, because the cord blood banking industry has matured substantially over the past few years, creating both serious threats and novel opportunities.

Therefore, judging individual company performance relative to the broader cord blood marketplace has become substantially more complex.
[Read more…]

Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

December 14, 2025 By BioInformant Team Leave a Comment

Singapore, 12 December 2025 – Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stability studies supported Shine-On’s IND submission. The IND was cleared by the U.S. FDA in Q1 2025. [Read more…]

Who Is CryoHoldco? Latin America’s Largest Cord Blood Bank

December 14, 2025 By Cade Hildreth, Founder & President Leave a Comment

CryoHoldco is a stem cell bank holding company that is the market leader in Latin America and the fifth largest cord blood banks globally. CryoHoldco is also many times larger than any other stem cell bank in Latin America, with over 400,000 stem cell units in storage.

[Read more…]

Cord Blood Banking Innovations and Their Impact on Personalized Medicine

December 14, 2025 By Marie Carroll Leave a Comment

Personalized medicine has rapidly transformed how healthcare is delivered. It has shifted the focus from generic treatments to therapies tailored to individual patients. No wonder the global personalized medicine market is set to witness phenomenal growth.

Central to this evolution is the use of stem cells, particularly those derived from cord blood. These cells, collected from a newborn’s umbilical cord, hold remarkable potential for treating a variety of diseases, including cancers, immune disorders, and genetic conditions. [Read more…]

Do You Know the Top Quality Guarantees Among U.S. Cord Blood Banks?

December 13, 2025 By Cade Hildreth, Founder & President Leave a Comment

Private cord blood banking continues to evolve in the United States, with several large companies offering storage of newborn stem cells for potential medical use by families. As of late 2025, Cord Blood Registry (CBR) remains the largest U.S. private cord blood bank, having stored more than one million cord blood and cord tissue units, making it significantly larger than many competitors and a clear industry leader.

In addition to CBR, other prominent private cord blood banks in the U.S. include ViaCord, Cryo-Cell International, and Americord Registry. These banks vary in experience, storage scale, services offered, and the specifics of their quality guarantee programs.

[Read more…]